Causes of death in long‐term bladder cancer survivors: A population‐based study

2019 ◽  
Vol 15 (5) ◽  
Author(s):  
Jianqiu Kong ◽  
Xiayao Diao ◽  
Feiyu Diao ◽  
Xinxiang Fan ◽  
Junjiong Zheng ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Survivors ◽  
Causes Of Death ◽  
Population Based ◽  
Population Based Study

scholarly journals Increased health care utilization among long-term cancer survivors compared to the average Dutch population: A population-based study

2007 ◽  
Vol 121 (4) ◽  
pp. 871-877 ◽  
Author(s):  
Floortje Mols ◽  
Kazimier A. Helfenrath ◽  
Ad J.J.M. Vingerhoets ◽  
Jan Willem W. Coebergh ◽  
Lonneke V. van de Poll-Franse
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Cancer Survivors ◽  
Population Based ◽  
Care Utilization ◽  
Dutch Population ◽  
Population Based Study

Bowel, Urinary, and Sexual Problems Among Long-Term Prostate Cancer Survivors: A Population-Based Study

2009 ◽  
Vol 73 (1) ◽  
pp. 30-38 ◽  
Author(s):  
Floortje Mols ◽  
Ida J. Korfage ◽  
Ad J.J.M. Vingerhoets ◽  
Paul J.M. Kil ◽  
Jan Willem W. Coebergh ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Survivors ◽  
Population Based ◽  
Sexual Problems ◽  
Population Based Study ◽  
Prostate Cancer Survivors

Long-term quality of life among localized prostate cancer survivors: Qalipro population-based study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 9594-9594
Author(s):  
Anne-Valérie Guizard ◽  
Clarisse Kerleau ◽  
Pascale Grosclaude ◽  
Mariette Mercier ◽  
Natacha Heutte ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Cancer Survivors ◽  
Population Based ◽  
Localized Prostate Cancer ◽  
Population Based Study ◽  
Prostate Cancer Survivors

scholarly journals Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients

2015 ◽  
Vol 94 (4) ◽  
pp. 383-389 ◽  
Author(s):  
Thomas Waldhoer ◽  
Ingrid Berger ◽  
Gerald Haidinger ◽  
Nadine Zielonke ◽  
Stephan Madersbacher
Keyword(s):  
Bladder Cancer ◽  
Cancer Survival ◽  
Population Based ◽  
Cancer Specific Survival ◽  
Population Based Study ◽  
Age Cohorts ◽  
Specific Mortality ◽  
Cancer Specific Mortality ◽  
The Relationship

Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (<70 years and ≥70 years) with higher tumour stages. Conclusions: This population-based study demonstrates that (1) a rise of advanced bladder cancer stages in women and (2) that women with tumour stages >pT1 have a shorter cancer-specific and overall survival.

Long-term cancer survivors experience work changes after diagnosis: results of a population-based study

2009 ◽  
Vol 18 (12) ◽  
pp. 1252-1260 ◽  
Author(s):  
Floortje Mols ◽  
Melissa S.Y. Thong ◽  
Gerard Vreugdenhil ◽  
Lonneke V. van de Poll-Franse
Keyword(s):  
Cancer Survivors ◽  
Population Based ◽  
Population Based Study

Quality of life in long-term cervical cancer survivors: A population-based study

2013 ◽  
Vol 129 (1) ◽  
pp. 222-228 ◽  
Author(s):  
Gwenael Le Borgne ◽  
Mariette Mercier ◽  
Anne-Sophie Woronoff ◽  
Anne-Valérie Guizard ◽  
Edwige Abeilard ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Cancer Survivors ◽  
Population Based ◽  
Population Based Study

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study

2007 ◽  
Vol 1 (1) ◽  
pp. 27-34 ◽  
Author(s):  
Kristina H. Karvinen ◽  
Kerry S. Courneya ◽  
Peter Venner ◽  
Scott North
Keyword(s):  
Bladder Cancer ◽  
Cancer Survivors ◽  
Population Based ◽  
Population Based Study

scholarly journals Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study

2021 ◽  
Author(s):  
Melissa S. Y. Thong ◽  
Daniela Doege ◽  
Linda Weißer ◽  
Lena Koch-Gallenkamp ◽  
Heike Bertram ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Cancer Diagnosis ◽  
Population Based ◽  
Additional Contribution ◽  
Population Based Study ◽  
Prostate Cancer Survivors ◽  
Regional Population ◽  
Prostate Cancers ◽  
After Cancer

Abstract Purpose Limited research suggests that cancer survivors have problems with insurance. Our study aimed to gain insight into the proportion of very long-term (14–24 years post-diagnosis) survivors of breast, colorectal, and prostate cancers who had problems with health (HI) and life (LI) insurance. Methods We used data from CAESAR (CAncEr Survivorship—A multi-Regional population-based study). Participants completed questions on change in insurance providers since cancer diagnosis, problems with requesting (additional) HI or LI, and how potential problems were resolved. We conducted logistic regression to determine factors associated with change in statutory HI. Results Of the 2714 respondents, 174 (6%) reported having changed HI providers. Most switched between different statutory HI providers (86%), 9% from statutory to private, and 5% from private to statutory. Respondents who changed statutory HI providers were more likely to be prostate cancer survivors (OR 2.79, 95% CI 1.01–7.68) while being ≥ 65 years at time of diagnosis (OR 0.58, 95% CI 0.35–0.96) and having ≥ 2 comorbid conditions (OR 0.61, 95% CI 0.40–0.92) were associated with reduced odds for change. Problems in changing HI were minimal and were resolved with additional contribution. Of the 310 respondents who tried to get LI, 25 respondents reported having difficulties, of whom the majority had their request rejected. Conclusion Most cancer survivors did not change their HI nor tried to buy LI after cancer diagnosis. Problems with changing statutory HI were generally resolved with additional contribution while the main problem encountered when buying LI was rejection of request.

Sign in / Sign up

Export Citation Format

Share Document